Explore

Healthy Living

News

Health A-Z

Calculators

Articles

Drugs

Directories

Education

More

Search Medindia

Medindia » Health Tips » Injectable Drug may Provide Long-term Protection against Malaria

Injectable Drug may Provide Long-term Protection against Malaria

Atovaquone, a new ''long-acting'' injectable medicine can provide longer protection against malarial plasmodium infections, finds a new study. The findings of this study are published in Nature Communications Journal. Every year, malaria afflicts hundreds of millions of people and kills hundreds of thousands of children. Despite considerable success in reducing the worldwide prevalence of malaria, its incidence in visitors to endemic areas has continued to rise steadily.

Injectable Drug may Provide Long-term Protection against Malaria

Injectable Drug may Provide Long-term Protection against Malaria

A new injectable formulation of an anitimalarial drug atovaquone can provide long term protection against Plasmodium berghei, a malaria causing parasite finds a new study.

Health Centers Specialty Health Quotes

Recommended Reading

Reduction In Cost Of Anti Malarial Drugs Thanks To New Process

Reduction In Cost Of Anti Malarial Drugs Thanks To New Process

Development of a new, higher-yield, two-step, less costly process that may ease supply problems and zigzagging prices for the raw material essential for making the mainstay drug for malaria.

Novel Ways to Combat Drug Resistance Discovered

Novel Ways to Combat Drug Resistance Discovered

A major research project conducted by University of Southampton biological scientists is aimed at making drugs more effective.

Resistance to First Line Anti-malarial Drugs is Increasing on the Thai-Myanmar Border: Study

Resistance to First Line Anti-malarial Drugs is Increasing on the Thai-Myanmar Border: Study

According to a study, early diagnosis and treatment with antimalarial drugs has been linked to a reduction in malaria in the migrant population living on the Thai-Myanmar border.

Ranbaxy Gets the Nod to Commence Distribution of Its Anti-malarial Drug in 7 African Countries

Ranbaxy Gets the Nod to Commence Distribution of Its Anti-malarial Drug in 7 African Countries

The Indian multinational pharmaceutical company, Ranbaxy Laboratories has received regulatory nod to launch its indigenously developed anti-malarial drug, Synriam, in seven African countries.

Health Tips

More...

Health Tips - Specialty

More...

⬆️